Page last updated: 2024-08-17

medroxyprogesterone acetate and Biliary Tract Diseases

medroxyprogesterone acetate has been researched along with Biliary Tract Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrett-Connor, E; Cauley, J; Furberg, C; Grady, D; Haskell, W; Hulley, S; Hunninghake, D; Knopp, R; Lowery, M; Satterfield, S; Schrott, H; Vittinghoff, E	1

Trials

1 trial(s) available for medroxyprogesterone acetate and Biliary Tract Diseases

Article	Year
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA, 2002, Jul-03, Volume: 288, Issue:1 Topics: Aged; Biliary Tract Diseases; Biliary Tract Surgical Procedures; Cause of Death; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Neoplasms; Postmenopause; Pulmonary Embolism; Risk Factors; Survival Analysis; Thromboembolism; Treatment Outcome; Venous Thrombosis	2002

Article

Year

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

JAMA, 2002, Jul-03, Volume: 288, Issue:1

Topics: Aged; Biliary Tract Diseases; Biliary Tract Surgical Procedures; Cause of Death; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Neoplasms; Postmenopause; Pulmonary Embolism; Risk Factors; Survival Analysis; Thromboembolism; Treatment Outcome; Venous Thrombosis

2002